Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchiectasis in children: orphan disease or persistent problem?

Charles W Callahan1, Gregory J Redding

  • 1Department of Pediatrics, Tripler Army Medical Center, Honolulu, Hawaii 96859-5000, USA. charles.callahan@amedd.army.mil

Pediatric Pulmonology
|May 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Diaphragm Intrusion and Thoracic Dimensions After Posterior Spinal Fusion in Patients With Neuromuscular Scoliosis.

Journal of pediatric orthopedics·2024
Same author

Chronic respiratory disease in Indigenous peoples: a framework to address inequity and strengthen respiratory health and health care globally.

The Lancet. Respiratory medicine·2024
Same author

Self-administered versus clinician-performed BinaxNOW COVID rapid test: a comparison of accuracy.

Microbiology spectrum·2024
Same author

Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical Therapy.

Journal of pediatric orthopedics·2023
Same author

Is Bronchiectasis a Reversible Disorder?

Archivos de bronconeumologia·2022
Same author

Pulmonary Function Testing in Children with Restrictive Chest Wall Disorders.

Pediatric allergy, immunology, and pulmonology·2022

Childhood bronchiectasis, once rare in developed nations, remains prevalent in lower socioeconomic groups and developing countries due to infections and environmental factors. Public health initiatives may be more impactful than medical treatments for this condition.

Area of Science:

  • Pediatrics
  • Pulmonology
  • Epidemiology

Background:

  • Bronchiectasis unrelated to cystic fibrosis was considered an orphan disease due to its rarity in developed countries.
  • However, it remains prevalent in lower socioeconomic classes and developing nations, linked to infections, environmental irritants, and malnutrition.
  • Persistently high rates are observed in specific populations, such as Southern Pacific and Alaska Native children, highlighting the need for updated global epidemiology.

Purpose of the Study:

  • To reassess the global importance of childhood bronchiectasis.
  • To explore the unclear reasons behind its development in some children.
  • To investigate the impact of asthma therapy in children with coexisting bronchiectasis and asthma.

Main Methods:

  • Review of existing epidemiological data and clinical observations.

Related Experiment Videos

  • Analysis of pathophysiological mechanisms including inflammation, mucus production, and airway obstruction.
  • Discussion of current treatment approaches, including antibiotic use and public health interventions.

    • Main Results:

    • Childhood bronchiectasis is more common in lower socioeconomic groups and developing countries.
    • Recurrent respiratory infections, environmental irritants, poor immunization, and malnutrition are presumed contributing factors.
    • The coexistence of asthma is associated with more severe disease, but its treatment impact is unstudied.

    Conclusions:

    • Better global epidemiologic data is required to understand childhood bronchiectasis.
    • The underlying causes for disease development in susceptible children remain unclear.
    • Public health measures focusing on living conditions and infection prevention, such as antiviral vaccines, may offer greater future impact than current medical treatments.